Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Controversial Role of LLMs in Medical Manuscript Writing - Dr. Pablo Moreno Franco
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Controversial Role of LLMs in Medical Manuscript Writing
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Why Start a Roth IRA Before Retirement | Michael Carrico - WEALTH MANAGER at Howe & Rusling
00:10:00
Platts GEA 2016 Industry Leader Award - Exploration and Production | Paul M. Rady, CEO, Antero Resources CorpAR:NYQ
00:10:00
AXA's Resilient Performance Amidst Geopolitical Uncertainty | Thomas Buberl, CEO , AXA Investment Managers.
00:10:00
The 20VC fund operates at the intersection of VC|Harry Stebbings,Founder,The 20VC Fund
00:10:00
Prashant Kumar on Reviving YES BANK and Future Growth Strategies | Prashant Kumar, CEO , Yes Bank Ltd.
00:00:00
Gil Beyen explains how Graspa works, its benefits and its other potential applications. - Gil Beyen, CEO, Erytech Pharma
00:10:00
APi Group CEO Russ Becker Appears on Mad Money with Jim Cramer | Russ Becker - Chief Executive Officer and President of APi Group Corp
00:10:00
Kodal Minerals CEO Discusses Lithium Market and Project Plans at 1-2-1 Conference in Cape Town
00:10:00
AR Revolutionizing Beauty Industry and Future of AR Commerce | Alice Chang, CEO, Perfect Corp.
00:10:00
Hot Chile Limited: Overview of Costa Fuego and Cordadera Discoveries
00:10:00
Artem Volynets Talks ACG SPAC Launch and Opportunity in New Economy Metals | Artem Volynets, CEO , ACG Acquisition Company Ltd.
00:10:00
BioInvent CEO Highlights Major Milestone and Future Goals | Dr. Martin Welschof, CEO , BioInvent International AB.